Singapore markets open in 2 hours 5 minutes

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.8700-0.0600 (-3.11%)
At close: 04:00PM EDT
1.9500 +0.08 (+4.28%)
After hours: 06:07PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.9300
Bid1.8900 x 100
Ask1.9300 x 200
Day's range1.8700 - 1.9899
52-week range1.0500 - 3.1600
Avg. volume239,007
Market cap116.971M
Beta (5Y monthly)1.10
PE ratio (TTM)N/A
EPS (TTM)-0.5100
Earnings date06 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.83
  • GlobeNewswire

    Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference

    BURLINGAME, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive officer, and Jeffrey Arcara, chief business officer, will conduct one-on-one meetings with investors and present a corporate overview at the Jefferies Global Health Conference, which is being held in New York from June 5-7, 2024. The Company’s presentation will be on Wednesday, Jun

  • Insider Monkey

    13 Penny Stocks with Insider Buying in 2024

    In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks with Insider Buying in 2024. Insider transactions have always drawn market attention as it’s now a well-known fact […]

  • Simply Wall St.

    Insider Spends US$1m Buying More Shares In Corvus Pharmaceuticals

    Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) shareholders (or potential shareholders) will be happy to see that the...